Purchase Order 75N95A19P00049

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. valued at $7,849 on November 14, 2017, with ultimate completion on November 13, 2018. The order is a firm fixed-price commercial acquisition with no set-aside. Work is performed in Pleasanton, California. The purchase order procures genomic analysis instruments, consumables, or related reagents from 10X Genomics' single-cell and spatial transcriptomics platform portfolio.</p>

The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. on December 28, 2020, for $11,864.00 under firm fixed price terms. Performance occurs in Pleasanton, California. The purchase order calls for genomic analysis platforms, reagents, or related consumables aligned with the vendor's product portfolio of single-cell and spatial transcriptomics technologies supporting neurological disease research. Ultimate completion was scheduled for January...

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. for $10,949.72 on April 2, 2021. The order, issued under firm fixed pricing, covers genomic analysis reagents and consumables supplied from the vendor's Pleasanton, California facility. The ultimate completion date was April 2, 2021.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. valued at $5,500 on May 24, 2018. Place of performance is Pleasanton, California. The order procures genomic analysis instruments, consumables, or reagents under firm fixed price terms. Ultimate completion date is May 23, 2019.</p>

The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. valued at $6,909.00 on May 1, 2018, for firm fixed price delivery with an ultimate completion date of April 30, 2019. Place of performance is Pleasanton, California. No set-aside was used. The order is for genomic analysis instruments, consumables, or bioinformatics software within 10X Genomics' core product portfolio of single-cell and spatial transcriptomics platforms and associated...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $10,155.30 firm fixed price delivery order to 10X Genomics, Inc. for optimization slides, reagents kits, and reagent delivery methods. The prime contractor, 10X Genomics, will provide the requested products and services from its Pleasanton, California location between September 12 and 27, 2023. The award was issued under an existing NIH vehicle to support...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $38,452 firm fixed price delivery order to 10X Genomics, Inc. for optimization slides, reagents kits, and reagent delivery methods. The prime contractor 10X Genomics will deliver the requested products and services from its Pleasanton, California location by October 9, 2023 in support of NIH NINDS programs. No subcontractors or set aside designations were...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $26,520.50 firm fixed price purchase order to 10X Genomics, Inc. for 10X multiple kits for genomics 5 GEMS library preparation. The place of performance is Pleasanton, California. The period of performance is from August 17, 2023 through August 22, 2023. This purchase order was awarded under an existing NIH vehicle to support the agency's genomics research...

The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order contract to 10X Genomics, Inc. for the provision of 10X Genomics RNA sequencing kits. The $40,289.50 contract has an ultimate completion date of October 25, 2020. There was no set-aside designation used for this award. The contract was issued under a larger indefinite delivery contract valued at up to $750,000...

<p>The National Institute on Aging awarded a purchase order to 10X Genomics, Inc. valued at $20,347.00 on June 16, 2017, with ultimate completion on July 16, 2017. The order is a firm fixed price acquisition with no set-aside. Work is performed in Baltimore, Maryland. The purchase order procures genomic analysis instruments, consumables, or reagent kits from 10X Genomics' single-cell and spatial transcriptomics platform portfolio.</p>